Fresenius Medical Care AG & Co KGaA (FMEG.DE)

FMEG.DE on Xetra

73.81EUR
12 Feb 2016
Change (% chg)

€2.04 (+2.84%)
Prev Close
€71.77
Open
€72.10
Day's High
€73.81
Day's Low
€71.19
Volume
807,660
Avg. Vol
734,188
52-wk High
€83.17
52-wk Low
€62.65

FMEG.DE

Chart for FMEG.DE

About

Fresenius Medical Care AG & Co. KGaA (FMC AG & CO. KGAA) is a kidney dialysis company. The Company provides dialysis care services related to the dialysis treatment a patient receives with end-stage renal disease (ESRD), as well as other health care services. FMC AG & CO. KGAA also provides dialysis products for the treatment of... (more)

Overall

Beta: 0.38
Market Cap(Mil.): €23,092.42
Shares Outstanding(Mil.): 312.86
Dividend: 0.78
Yield (%): 1.06

Financials

  FMEG.DE Industry Sector
P/E (TTM): 24.45 28.10 37.45
EPS (TTM): 3.02 -- --
ROI: 7.03 6.21 14.17
ROE: 11.72 10.06 14.92
Search Stocks

BRIEF-Fresenius medical care says Asia-Pac board member resigns

* Roberto Fuste (64), the management board member responsible for the region Asia-Pacific, has decided to resign Further company coverage:

28 Jan 2016

FMC seeks growth outside main U.S. market

FRANKFURT Fresenius Medical Care , the world's largest dialysis provider, is looking for opportunities to grow in Europe and Asia as it feels the limits to growth in its largest market, the United States, its chief executive told Reuters in an interview.

23 Nov 2015

FMC sees growth outside main U.S. market

FRANKFURT Fresenius Medical Care , the world's largest dialysis provider, is looking for opportunities to grow in Europe and Asia as it feels the limits to growth in its largest market, the United States, its chief executive told Reuters in an interview.

23 Nov 2015

BRIEF-FMC and Debiotech announce partnership for home dialysis product development

* Debiotech and Fresenius Medical Care announce exclusive partnership for new home dialysis product development

03 Nov 2015

German stocks - Factors to watch on October 29

FRANKFURT, Oct 29 The DAX top-30 index looked set to open 0.5 percent higher on Thursday, according to premarket data from brokerage Lang & Schwarz at 0723 GMT.

29 Oct 2015

UPDATE 1-Fresenius raises profit guidance again on drug demand

* Subsidiary FMC Q3 net income down 3 pct (Adds infusion drugs industry background, FMC results)

29 Oct 2015

FMC keeps 2016 sales forecast

FRANKFURT, Oct 29 Kidney dialysis specialist Fresenius Medical Care (FMC), the separately listed subsidiary of Fresenius SE, on Thursday confirmed its projections for 2016 sales growth of 7-10 percent.

29 Oct 2015

Fresenius Medical Care buys dialysis specialist Nephromor -paper

FRANKFURT, Oct 23 Kidney dialysis specialist Fresenius Medical Care is buying Israel-based peer Nephromor for about 350 million shekels ($90.23 million), German business paper Frankfurter Allgemeine Zeitung reported on Friday, citing industry sources.

23 Oct 2015

Fresenius CEO says would look at medical nutrition assets

FRANKFURT, Oct 6 German healthcare group Fresenius has its sights trained on takeovers in the medical nutrition market, its chief executive said -- even after it failed, according to sources, to purchase a large Danone business last year.

06 Oct 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : ValuEngine, Inc.
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Ford Investor Services, Inc.
$12.00
Provider : Finlabo SIM Spa
$10.00
Provider : S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks